Abbott (NYSE: ABT) today announced a unique global partnership with Medtronic to collaborate on an integrated continuous glucose monitoring (CGM) system based on Abbott's most advanced, world-leading FreeStyle Libre technology that will connect with Medtronic's automated insulin delivery (AID) and smart insulin pen systems.

Medtronic has received a CE mark for its continuous glucose monitoring (CGM) device, Simplera, allowing the device to be marketed in the European Union.

POCT is a clinical test that is performed next to the patient and sampled on-site for immediate analysis. Simplicity and convenience are always the most important features of POCT.

Outpatient testing must not be encouraged, promoted or advertised. Persons with COVID-like illness not requiring hospitalization should be instructed to stay home. It is safer for the patients and health care workers and testing does not cu

Bacillusbacteria detection devices were previously unclassified, known as preamendment devices, since they were in commercial distribution prior to May 28, 1976, when the Medical Device Amendments to the Federal Food, Drug, and Cosmetic Act

Through a newly announced partnership with Fabric Genomics, genetic testing company Diagnomics has developed an ACMG-59 report to help healthcare provider organizations understand pathogenic and likely pathogenic variants. The ACMG-59 is a